Literature DB >> 1764764

Potential of the scid mouse as a host for human tumors.

B M Mueller1, R A Reisfeld.   

Abstract

Animal models of human tumors and their metastases that effectively mimic clinical disease are in considerable demand. While it is certainly true that athymic nude mice provide us with useful models to study a large number of human tumors in vivo, it is also well known that nude mice usually do not develop spontaneous metastases and are not suitable for all types of tumors. Therefore, the scid mouse that allows disseminated growths for a number of human tumors, particularly hematologic disorders and malignant melanoma, can be used preferentially for the investigation of such malignancies. The potential to study the interaction of human immune cells and human tumor in an in vivo model is another unique feature of scid mice that will add to their usefulness in experimental cancer research.

Entities:  

Mesh:

Year:  1991        PMID: 1764764     DOI: 10.1007/bf00050791

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  29 in total

1.  Natural killer cells in the thymus. Studies in mice with severe combined immune deficiency.

Authors:  B A Garni-Wagner; P L Witte; M M Tutt; W A Kuziel; P W Tucker; M Bennett; V Kumar
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

2.  Enhanced tumorigenicity, melanogenesis, and metastases of a human malignant melanoma after subdermal implantation in nude mice.

Authors:  I Cornil; S Man; B Fernandez; R S Kerbel
Journal:  J Natl Cancer Inst       Date:  1989-06-21       Impact factor: 13.506

3.  Suppression of spontaneous melanoma metastasis in scid mice with an antibody to the epidermal growth factor receptor.

Authors:  B M Mueller; C A Romerdahl; J M Trent; R A Reisfeld
Journal:  Cancer Res       Date:  1991-04-15       Impact factor: 12.701

4.  Human lung tumors, patients' peripheral blood lymphocytes and tumor infiltrating lymphocytes propagated in scid mice.

Authors:  R B Bankert; T Umemoto; Y Sugiyama; F A Chen; E Repasky; S Yokota
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

5.  Growth of human tumors in immune-deficient scid mice and nude mice.

Authors:  R A Phillips; M A Jewett; B L Gallie
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

6.  Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms.

Authors:  R P Custer; G C Bosma; M J Bosma
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

7.  Human lung tumor growth established in the lung and subcutaneous tissue of mice with severe combined immunodeficiency.

Authors:  S Reddy; D Piccione; H Takita; R B Bankert
Journal:  Cancer Res       Date:  1987-05-01       Impact factor: 12.701

8.  Suppression of HIV infection in AZT-treated SCID-hu mice.

Authors:  J M McCune; R Namikawa; C C Shih; L Rabin; H Kaneshima
Journal:  Science       Date:  1990-02-02       Impact factor: 47.728

9.  Human immunodeficiency virus infection of human-PBL-SCID mice.

Authors:  D E Mosier; R J Gulizia; S M Baird; D B Wilson; D H Spector; S A Spector
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

10.  Disseminated human malignant melanoma in congenitally immune-deficient (bg/nu/xid) mice.

Authors:  J J Mulé; D L Jicha; P M Aebersold; W D Travis; S A Rosenberg
Journal:  J Natl Cancer Inst       Date:  1991-03-06       Impact factor: 13.506

View more
  22 in total

Review 1.  SCID mice in the study of human autoimmune diseases.

Authors:  M A Duchosal
Journal:  Springer Semin Immunopathol       Date:  1992

2.  In vitro models of pancreatic cancer for translational oncology research.

Authors:  Georg Feldmann; Sherri Rauenzahn; Anirban Maitra
Journal:  Expert Opin Drug Discov       Date:  2009-04-01       Impact factor: 6.098

Review 3.  The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research.

Authors:  Logan C DeBord; Ravi R Pathak; Mariana Villaneuva; Hsuan-Chen Liu; Daniel A Harrington; Wendong Yu; Michael T Lewis; Andrew G Sikora
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

Review 4.  Human cancer growth and therapy in immunodeficient mouse models.

Authors:  Leonard D Shultz; Neal Goodwin; Fumihiko Ishikawa; Vishnu Hosur; Bonnie L Lyons; Dale L Greiner
Journal:  Cold Spring Harb Protoc       Date:  2014-07-01

5.  An orthotopic, postsurgical model of luciferase transfected murine osteosarcoma with spontaneous metastasis.

Authors:  Joseph L Sottnik; Dawn L Duval; E J Ehrhart; Douglas H Thamm
Journal:  Clin Exp Metastasis       Date:  2010-03-07       Impact factor: 5.150

6.  Human villous adenomas engrafted into scid mice survive for prolonged period without malignant transformation.

Authors:  H L Bumpers; T R Alosco; H Q Wang; N J Petrelli; E L Hoover; R B Bankert
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

7.  Non-fastidious, melanoma-specific CD8+ cytotoxic T lymphocytes from choroidal melanoma patients.

Authors:  X Q Huang; M S Mitchell; P E Liggett; A L Murphree; J Kan-Mitchell
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

8.  Platelet glycoprotein Ib alpha supports experimental lung metastasis.

Authors:  Shashank Jain; Masahiko Zuka; Jungling Liu; Susan Russell; Judith Dent; José A Guerrero; Jane Forsyth; Brigid Maruszak; T Kent Gartner; Brunhilde Felding-Habermann; Jerry Ware
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205

9.  p-[123I]iodo-L-phenylalanine for detection of pancreatic cancer: basic investigations of the uptake characteristics in primary human pancreatic tumour cells and evaluation in in vivo models of human pancreatic adenocarcinoma.

Authors:  Samuel Samnick; Bernd F M Romeike; Boris Kubuschok; Dirk Hellwig; Michaela Amon; Wolfgang Feiden; Michael D Menger; Carl-Martin Kirsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

10.  Glycosylation patterns of the human colon cancer cell line HT-29 detected by Helix pomatia agglutinin and other lectins in culture, in primary tumours and in metastases in SCID mice.

Authors:  U Schumacher; E Adam; D J Flavell; D Boehm; S A Brooks; A J Leathem
Journal:  Clin Exp Metastasis       Date:  1994-11       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.